Color enhancement: Difference between revisions

Line 1:

'''Color enhancement''' can be described as the experience of colors becoming extremely bright or vivid and standing out. During this experience, reds may seem “redder”, greens may seem “greener, ” etc and all colors will likely have become much more distinct, powerful and intense to look at than they comparatively would be during everyday sober living.

'''Color enhancement''' can be described as the experience of colors becoming extremely bright or vivid and standing out. During this experience, reds may seem “redder”, greens may seem “greener, ” etc and all colors will likely have become much more distinct, powerful and intense to look at than they comparatively would be during everyday sober living. <ref name="DecreasedHueDiscrimination">Hartman, A. M., & Hollister, L. E. (1963). Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception. Psychopharmacologia, 4(6), 449-451. https://doi.org/10.1007/BF00403349</ref><ref name="ImpossibleColours">Kleinman, J. E., Gillin, J. C., & Wyatt, R. J. (1977). A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Schizophrenia Bulletin, 3(4), 562-567. https://dx.doi.org/10.1093/schbul/3.4.560</ref><ref>Gallimore, A. R. (2015). Restructuring consciousness–the psychedelic state in light of integrated information theory. Frontiers in human neuroscience, 9, 346. https://dx.doi.org/10.3389%2Ffnhum.2015.00346</ref><ref>Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS. PHARMACIA, 64(1), 41-42. https://www.researchgate.net/profile/Violina_Angelova2/publication/317528151_Pharmaco-toxicological_aspects_and_analysis_of_phenylalkylamine_and_indolylallkylamine_hallucinogens_Review/links/593d59f50f7e9b3317a45adf/Pharmaco-toxicological-aspects-and-analysis-of-phenylalkylamine-and-indolylallkylamine-hallucinogens-Review.pdf</ref><ref>Luke, D., & Terhune, D. B. (2013). The induction of synaesthesia with chemical agents: a systematic review. Frontiers in psychology, 4, 753. https://dx.doi.org/10.3389%2Ffpsyg.2013.00753</ref><ref>Dillon, P., Copeland, J., & Jansen, K. (2003). Patterns of use and harms associated with non-medical ketamine use. Drug & Alcohol Dependence, 69(1), 26. https://doi.org/10.1016/S0376-8716(02)00243-0</ref><ref name="25B_multiple>Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 4. https://doi.org/10.1007/s11419-014-0242-9</ref><ref name="25C_multiple">Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan Mariotti Posocco, F., ... & Schifano, F. (2014). 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. BioMed Research International, 2014. https://dx.doi.org/10.1155%2F2014%2F734749</ref>

Colour enhancement is often accompanied by other coinciding effects such as [[acuity enhancement]] and [[pattern recognition enhancement]]. It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].

Studies have also suggested an accompanying effect of decreased hue discrimination resulting in autobiographical accounts of impossible colors. <ref name="DecreasedHueDiscrimination"/><ref name="ImpossibleColours"/>

Colour enhancement is often accompanied by other coinciding effects such as [[acuity enhancement]] and [[pattern recognition enhancement]].<ref name="25B_multiple"/><ref name="25C_multiple"/> It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].

====Image examples====

@@ Line 1: / Line 1: @@
 <onlyinclude>
-'''Color enhancement''' can be described as the experience of colors becoming extremely bright or vivid and standing out. During this experience, reds may seem “redder”, greens may seem “greener, ” etc and all colors will likely have become much more distinct, powerful and intense to look at than they comparatively would be during everyday sober living.
+'''Color enhancement''' can be described as the experience of colors becoming extremely bright or vivid and standing out. During this experience, reds may seem “redder”, greens may seem “greener, ” etc and all colors will likely have become much more distinct, powerful and intense to look at than they comparatively would be during everyday sober living. <ref name="DecreasedHueDiscrimination">Hartman, A. M., & Hollister, L. E. (1963). Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception. Psychopharmacologia, 4(6), 449-451. https://doi.org/10.1007/BF00403349</ref><ref name="ImpossibleColours">Kleinman, J. E., Gillin, J. C., & Wyatt, R. J. (1977). A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Schizophrenia Bulletin, 3(4), 562-567. https://dx.doi.org/10.1093/schbul/3.4.560</ref><ref>Gallimore, A. R. (2015). Restructuring consciousness–the psychedelic state in light of integrated information theory. Frontiers in human neuroscience, 9, 346. https://dx.doi.org/10.3389%2Ffnhum.2015.00346</ref><ref>Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS. PHARMACIA, 64(1), 41-42. https://www.researchgate.net/profile/Violina_Angelova2/publication/317528151_Pharmaco-toxicological_aspects_and_analysis_of_phenylalkylamine_and_indolylallkylamine_hallucinogens_Review/links/593d59f50f7e9b3317a45adf/Pharmaco-toxicological-aspects-and-analysis-of-phenylalkylamine-and-indolylallkylamine-hallucinogens-Review.pdf</ref><ref>Luke, D., & Terhune, D. B. (2013). The induction of synaesthesia with chemical agents: a systematic review. Frontiers in psychology, 4, 753. https://dx.doi.org/10.3389%2Ffpsyg.2013.00753</ref><ref>Dillon, P., Copeland, J., & Jansen, K. (2003). Patterns of use and harms associated with non-medical ketamine use. Drug & Alcohol Dependence, 69(1), 26. https://doi.org/10.1016/S0376-8716(02)00243-0</ref><ref name="25B_multiple>Papoutsis, I., Nikolaou, P., Stefanidou, M., Spiliopoulou, C., & Athanaselis, S. (2015). 25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers. Forensic Toxicology, 33(1), 4. https://doi.org/10.1007/s11419-014-0242-9</ref><ref name="25C_multiple">Bersani, F. S., Corazza, O., Albano, G., Valeriani, G., Santacroce, R., Bolzan Mariotti Posocco, F., ... & Schifano, F. (2014). 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. BioMed Research International, 2014. https://dx.doi.org/10.1155%2F2014%2F734749</ref>
-Colour enhancement is often accompanied by other coinciding effects such as [[acuity enhancement]] and [[pattern recognition enhancement]]. It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].
+Studies have also suggested an accompanying effect of decreased hue discrimination resulting in autobiographical accounts of impossible colors. <ref name="DecreasedHueDiscrimination"/><ref name="ImpossibleColours"/>
+Colour enhancement is often accompanied by other coinciding effects such as [[acuity enhancement]] and [[pattern recognition enhancement]].<ref name="25B_multiple"/><ref name="25C_multiple"/> It is most commonly induced under the influence of [[dosage#mild|mild]] [[dosage|dosages]] of [[psychedelic]] compounds, such as [[LSD]], [[psilocybin]], and [[mescaline]]. However, it can also occur to a lesser extent under the influence of certain [[stimulants]] and [[dissociatives]] such as [[MDMA]] or [[3-MeO-PCP]].
 ====Image examples====
 <center>